"Targeting AhR suppresses hepatocyte ferroptosis in MASH by regulating the Pten/Akt/β catenin axis" [Biochem. Pharmacol. 232 (2025) 116711]
文献类型：期刊论文
| 作者 | Ma, Chenhui1,3,4; Han, Li3,4; Zhao, Wenxuan2; Chen, Feihong3,4; Huang, Ruimin2,3,4 ; Pang, Cheng Heng1; Zhu, Zheying5; Pan, Guoyu2,3,4
|
| 刊名 | BIOCHEMICAL PHARMACOLOGY
 |
| 出版日期 | 2025-05-01 |
| 卷号 | 235页码:1 |
| ISSN号 | 0006-2952 |
| DOI | 10.1016/j.bcp.2025.116823 |
| 通讯作者 | Huang, Ruimin(rmhuang@simm.ac.cn) ; Pang, Cheng Heng(chengheng.pang@nottingham.edu.cn) ; Zhu, Zheying(Zheying.Zhu@nottingham.ac.uk) ; Pan, Guoyu(gypan@simm.ac.cn) |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:001435427300001 |
| 出版者 | PERGAMON-ELSEVIER SCIENCE LTD |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/316472]  |
| 专题 | 中国科学院上海药物研究所 |
| 通讯作者 | Huang, Ruimin; Pang, Cheng Heng; Zhu, Zheying; Pan, Guoyu |
| 作者单位 | 1.Univ Nottingham Ningbo China, Dept Chem & Environm Engn, Ningbo 315100, Peoples R China 2.Nanjing Univ Chinese Med, Nanjing 210029, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 4.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China 5.Univ Nottingham, Div Mol Therapeut & Formulat, Sch Pharm, Univ Pk Campus, Nottingham NG7 2RD, England |
| 推荐引用方式 GB/T 7714 | Ma, Chenhui,Han, Li,Zhao, Wenxuan,et al. "Targeting AhR suppresses hepatocyte ferroptosis in MASH by regulating the Pten/Akt/β catenin axis" [Biochem. Pharmacol. 232 (2025) 116711][J]. BIOCHEMICAL PHARMACOLOGY,2025,235:1. |
| APA | Ma, Chenhui.,Han, Li.,Zhao, Wenxuan.,Chen, Feihong.,Huang, Ruimin.,...&Pan, Guoyu.(2025)."Targeting AhR suppresses hepatocyte ferroptosis in MASH by regulating the Pten/Akt/β catenin axis" [Biochem. Pharmacol. 232 (2025) 116711].BIOCHEMICAL PHARMACOLOGY,235,1. |
| MLA | Ma, Chenhui,et al.""Targeting AhR suppresses hepatocyte ferroptosis in MASH by regulating the Pten/Akt/β catenin axis" [Biochem. Pharmacol. 232 (2025) 116711]".BIOCHEMICAL PHARMACOLOGY 235(2025):1. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。